<SEC-DOCUMENT>0001437749-16-023475.txt : 20160112
<SEC-HEADER>0001437749-16-023475.hdr.sgml : 20160112
<ACCEPTANCE-DATETIME>20160112080014
ACCESSION NUMBER:		0001437749-16-023475
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20160112
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20160112
DATE AS OF CHANGE:		20160112

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIO KEY INTERNATIONAL INC
		CENTRAL INDEX KEY:			0001019034
		STANDARD INDUSTRIAL CLASSIFICATION:	COMPUTER COMMUNICATIONS EQUIPMENT [3576]
		IRS NUMBER:				411761861
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13463
		FILM NUMBER:		161337648

	BUSINESS ADDRESS:	
		STREET 1:		3349 HIGHWAY 138
		STREET 2:		BUIDING A, SUITE E
		CITY:			WALL
		STATE:			NJ
		ZIP:			07719
		BUSINESS PHONE:		7323591100

	MAIL ADDRESS:	
		STREET 1:		3349 HIGHWAY 138
		STREET 2:		BUIDING A, SUITE E
		CITY:			WALL
		STATE:			NJ
		ZIP:			07719

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SAC TECHNOLOGIES INC
		DATE OF NAME CHANGE:	19961115
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>bkyi20160111_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD><TITLE>bkyi20160111_8k.htm</TITLE>
<!-- Created by RDG HTML Converter -->
</HEAD>
<BODY style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; MARGIN-LEFT: 10px; MARGIN-RIGHT: 10px">
<P id=PARA1 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, Times, serif"><B>&nbsp;</B></FONT></P>
<P id=PARA3 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, Times, serif"><B>UNITED STATES</B></FONT></P>
<P id=PARA4 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, Times, serif"><B>SECURITIES AND EXCHANGE COMMISSION</B></FONT></P>
<P id=PARA5 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA6 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, Times, serif">Washington, D.C. 20549</FONT></P>
<P id=PARA7 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA8 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, Times, serif"><B>FORM 8-K</B></FONT></P>
<P id=PARA9 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA10 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, Times, serif"><B>CURRENT REPORT</B></FONT></P>
<P id=PARA11 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA12 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Pursuant to Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934</FONT></P>
<P id=PARA13 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA14 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Date of Report (Date of earliest event reported): January 12, 2016</FONT></P>
<P id=PARA15 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</P>
<P id=PARA16 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=TBL39S1  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 101.1%; VERTICAL-ALIGN: top" colSpan=3>
<P id=PARA17 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 18pt; FONT-FAMILY: Times New Roman, Times, serif"><B>BIO-key International, Inc.</B></FONT></P>
<P id=PARA20 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(Exact name of registrant as specified in its charter)</FONT></P></TD></TR></TABLE>
<P id=PARA69 style="MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</P>
<P style="MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</P>
<TABLE id=TBL39S1  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 33%; VERTICAL-ALIGN: top">
<P id=PARA21 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Delaware</B></FONT></P>
<P id=PARA22 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(State or other jurisdiction of</FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">incorporation)</FONT></P></TD>
<TD style="WIDTH: 34%; VERTICAL-ALIGN: top">
<P id=PARA23 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>1-13463</B></FONT></P>
<P id=PARA24 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(Commission File Number)</FONT></P></TD>
<TD style="WIDTH: 33%; VERTICAL-ALIGN: top">
<P id=PARA25 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>41-1741861</B></FONT></P>
<P id=PARA26 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(I.R.S. Employer Identification No.)</FONT></P></TD></TR></TABLE>
<P id=PARA70 style="MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</P>
<P style="MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</P>
<TABLE id=TBL39S1  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 101.1%; VERTICAL-ALIGN: top" colSpan=3>
<P id=PARA27 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>3349 Highway 138, Building A, Suite E</B></FONT></P>
<P id=PARA29 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Wall, NJ&nbsp;07719</B></FONT></P>
<P id=PARA30 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(Address of principal executive offices)</FONT></P></TD></TR></TABLE>
<P id=PARA71 style="MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</P>
<P style="MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</P>
<TABLE id=TBL39S1  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 101.1%; VERTICAL-ALIGN: top" colSpan=3>
<P id=PARA31 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>(732)&nbsp;359-1100</B></FONT></P>
<P id=PARA33 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(Registrant&#8217;s telephone number, including area code)</FONT></P></TD></TR></TABLE>
<P id=PARA72 style="MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</P>
<P id=PARA34 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<I>see</I> General Instruction A.2 below):</FONT></P>
<P style="MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</P>
<TABLE id=TBL39  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 3%; VERTICAL-ALIGN: top">&#9744;</TD>
<TD style="WIDTH: 97%; VERTICAL-ALIGN: top">
<P id=PARA35 style="TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 3%; VERTICAL-ALIGN: top">&nbsp;</TD>
<TD style="WIDTH: 97%; VERTICAL-ALIGN: top">&nbsp;</TD></TR>
<TR>
<TD style="WIDTH: 3%; VERTICAL-ALIGN: top">&#9744;</TD>
<TD style="WIDTH: 97%; VERTICAL-ALIGN: top"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
<TR>
<TD style="WIDTH: 3%; VERTICAL-ALIGN: top">&nbsp;</TD>
<TD style="WIDTH: 97%; VERTICAL-ALIGN: top">&nbsp;</TD></TR>
<TR>
<TD style="WIDTH: 3%; VERTICAL-ALIGN: top">&#9744;</TD>
<TD style="WIDTH: 97%; VERTICAL-ALIGN: top"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
<TR>
<TD style="WIDTH: 3%; VERTICAL-ALIGN: top">&nbsp;</TD>
<TD style="WIDTH: 97%; VERTICAL-ALIGN: top">&nbsp;</TD></TR>
<TR>
<TD style="WIDTH: 3%; VERTICAL-ALIGN: top">&#9744;</TD>
<TD style="WIDTH: 97%; VERTICAL-ALIGN: top"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Pre-commencement communications pursuant to Rule 13e-4(c) under Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR></TABLE>
<P id=PARA40.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK40  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR40  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM40  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR40  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA40.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<P id=PARA41 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Item 2.02.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Results of Operations and Financial Condition.</B></FONT></P>
<P id=PARA42 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA43 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On January 12, 2016, the Chairman and Chief Executive Officer of BIO-key International, Inc. (the &#8220;Company&#8221;) issued a letter to the Company&#8217;s shareholders.&nbsp; &nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The letter provides certain operational highlights regarding the Company as well as information regarding the Company&#8217;s anticipated financial results for the fourth quarter of 2015. A copy of the letter issued by the Company on January 12, 2016 is attached as Exhibit&nbsp;99.1. </FONT></P>
<P id=PARA44 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA45 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The information, including the exhibit attached hereto, in this Current Report on Form 8-K shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as otherwise expressly stated in such filing.</FONT></P>
<P id=PARA46 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT></P>
<P id=PARA48 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA49 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Item 9.01.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits.</B></FONT></P>
<P id=PARA50 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA51 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;Exhibits</FONT></P>
<P id=PARA52 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA53 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">99.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shareholder letter, dated January 12, 2016, issued by </FONT><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">the Chairman and CEO of BIO-key International.</FONT></P>
<P id=PARA54 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA55 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA56 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>SIGNATURES</B></FONT></P>
<P id=PARA57 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA58 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</FONT></P>
<P id=PARA59 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA60 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT>&nbsp;</P>
<TABLE id=MTAB66  style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 52%">&nbsp;</TD>
<TD style="MARGIN-BOTTOM: 0px; WIDTH: 43%; VERTICAL-ALIGN: top; MARGIN-TOP: 0px" colSpan=3>
<P id=PARA62 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">BIO-KEY INTERNATIONAL, INC.</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 52%">
<P id=PARA63 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Date: January 12, 2016</FONT></P></TD>
<TD style="WIDTH: 3%; VERTICAL-ALIGN: top">&nbsp;</TD>
<TD style="WIDTH: 40%; VERTICAL-ALIGN: top">&nbsp;</TD>
<TD style="WIDTH: 5%; VERTICAL-ALIGN: top">&nbsp;</TD></TR>
<TR>
<TD style="WIDTH: 52%">&nbsp;</TD>
<TD style="WIDTH: 3%; VERTICAL-ALIGN: top">
<P id=PARA67 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">By: </FONT></P></TD>
<TD style="WIDTH: 40%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid">
<P id=PARA68 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">/s/ Cecilia C. Welch</FONT></P></TD>
<TD style="WIDTH: 5%; VERTICAL-ALIGN: top">&nbsp;</TD></TR>
<TR>
<TD style="WIDTH: 52%">&nbsp;</TD>
<TD style="WIDTH: 3%; VERTICAL-ALIGN: top">&nbsp;</TD>
<TD style="WIDTH: 40%; VERTICAL-ALIGN: top">Cecilia C. Welch<BR>Chief Financial Officer</TD>
<TD style="WIDTH: 5%; VERTICAL-ALIGN: top">&nbsp;</TD></TR></TABLE></BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML><HEAD><TITLE>ex99-1.htm</TITLE>
<!-- Created by RDG HTML Converter -->
</HEAD>
<BODY style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; MARGIN-LEFT: 10px; MARGIN-RIGHT: 10px">
<P id=PARA84 style="MARGIN-BOTTOM: 0px; TEXT-ALIGN: right; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Exhibit 99.1</B></FONT></P>
<P id=PARA85 style="MARGIN-BOTTOM: 0px; TEXT-ALIGN: left; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE  style="TEXT-INDENT: 0;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%" cellSpacing=0 cellPadding=0>

<TR>
<TD style="WIDTH: 50%">
<P id=PARA82 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt">&nbsp;<IMG src="logo.jpg" width=175 height=44></P></TD>
<TD style="WIDTH: 50%">
<P id=PARA83 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: right; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 18pt; FONT-FAMILY: Times New Roman, Times, serif"><I><B>NEWS RELEASE</B></I></FONT></P></TD></TR></TABLE>
<P id=PARA2 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</P>
<P id=PARA6 style="TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman, Times, serif"><B>BIO-key CEO Updates Shareholders on Progress and Outlook</B></FONT></P>
<P id=PARA8 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA7 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Wall, NJ, January 12, 2016</B> - BIO-key International, Inc. (OTCBB: BKYI), a global biometric identification software and technology solutions provider, today updated its shareholders on the Company&#8217;s progress and outlook in the form of a letter from Michael DePasquale, BIO-key&#8217;s Chairman &amp; CEO. The text of the letter follows:</FONT></P>
<P id=PARA9 style="MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA10 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><BR><B>January 12, 2016</B></FONT></P>
<P id=PARA11 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA12 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Dear Fellow BIO-key Shareholders,</FONT></P>
<P id=PARA13 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA14 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The past year was a period of unprecedented growth and transformation for our Company, our portfolio of biometric solutions and our geographic reach. We believe our efforts during the past year fortified our organization in several key respects, making us financially and operationally stronger and positioning us for a far broader base of global growth opportunities.</FONT></P>
<P id=PARA15 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA16 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Importantly, <B>BIO-key addresses a fundamental problem &#8211; the secure authentication of individuals seeking access to critical data or to execute transactions</B> &#8211; which remains insufficiently addressed in the vast majority of cases. We believe that BIO-key&#8217;s robust biometric authentication solutions represent a secure, efficient and cost-effective method to solve most authentication challenges, and we are now positioned to accelerate our pursuit of these opportunities on a global basis.</FONT></P>
<P id=PARA17 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA18 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Fingerprint Readers Enable Turnkey Solution Offering</B></FONT></P>
<P id=PARA19 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">One of the clear catalysts for BIO-key&#8217;s growth in 2015 was the introduction of a series of compact, cost effective fingerprint readers, SideSwipe and EcoID. These products, which we believe will act as catalysts for growth in 2016 and beyond, have helped BIO-key evolve into a provider of larger, more comprehensive solutions. Our fingerprint readers have been well received in the market because of their quality, small form factor, and ease of installation combined with pricing that is roughly half that of other readers. </FONT></P>
<P id=PARA20 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA21 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The goal of this initiative was to bridge the fingerprint biometric utilization gap. So far the results have been encouraging. We now have a number of prospects and customers that have purchased and deployed our reader solutions or are testing them for future use. To further simplify enterprise and consumer deployment, in Q1 2016 we plan to introduce another compact reader that is designed to operate on all Windows, Linux and Android devices. </FONT></P>
<P id=PARA22 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA23 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Strong Finish to 2015</B></FONT></P>
<P id=PARA24 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">While our results are not yet final, we closed out 2015 with a strong Q4 performance that exceeded both the bottom end of our revenue guidance range of $1.4M to $2.2M as well as our year-ago Q4 revenue of $952,000. Based on this performance, our full year 2015 revenues are slated to fall within our guidance range of $5.0 - $6.0 million, an increase of at least 25% over 2014 revenues of $4.0 million.</FONT></P>
<P id=PARA25 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA26 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Beyond our revenue growth BIO-key, structured and completed a significant strategic partnership and equity financing in the later part of 2015. This technology license and strategic investment by China Goldjoy Group Limited and affiliates provided us with the financial strength and resources to accelerate our sales, marketing and R&amp;D efforts in 2016 and beyond. We have also commenced the integration of China Goldjoy&#8217;s FingerQ software into the BIO-key platform as part of our previously announced plans to enter the global payment market. </FONT></P>
<P id=PARA86.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK86  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR86  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM86  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR86  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA86.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></FONT>&nbsp;</P>
<P id=PARA28 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Fourth Quarter Highlights</B></FONT></P>
<P id=PARA29 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<TABLE id=MTAB31  style="TEXT-INDENT: 0;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 18pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA32 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA33 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Closed a $485K order with a large regional healthcare institution that will utilize our biometric solutions to meet two factor authentication requirements for Electronically Prescribed Controlled Substances and access to Electronic Medical Records. </FONT></P></TD></TR></TABLE>
<TABLE id=MTAB35  style="TEXT-INDENT: 0;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 18pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA36 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA37 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Completed a $375k follow-on order with NCR for enabling secure, biometric enabled access to their network of point of sale terminals.</FONT></P></TD></TR></TABLE>
<TABLE id=MTAB39  style="TEXT-INDENT: 0;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 18pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA40 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA41 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Our Hong Kong subsidiary BIO-key HK Ltd., through our new strategic partnership with China Goldjoy, delivered an initial fingerprint biometric solution to a global payments company. The sale was valued at $244K. </FONT></P></TD></TR></TABLE>
<TABLE id=MTAB43  style="TEXT-INDENT: 0;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 18pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA44 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA45 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Executed a $180K contract with a multi-factor authentication company to utilize our solutions in the healthcare and services market.</FONT></P></TD></TR></TABLE>
<TABLE id=MTAB47  style="TEXT-INDENT: 0;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 18pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA48 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA49 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Collaborated with Microsoft on a 12-city tour that provided excellent visibility for our biometric solutions for Windows 10 and Office 2016. This joint marketing effort has led to a broad range of initial interest in our solutions from a range of customers, and we look forward to additional joint marketing efforts in the coming months.</FONT></P></TD></TR></TABLE>
<TABLE id=MTAB51  style="TEXT-INDENT: 0;FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%" cellSpacing=0 cellPadding=0 border=0>

<TR>
<TD style="WIDTH: 18pt">&nbsp;</TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P id=PARA52 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#9679;</FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P id=PARA53 style="MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Continued solid demand for our secure authentication solutions to support the rollout of medication management solutions provided by Aesynt, a former subsidiary of McKesson.</FONT></P></TD></TR></TABLE>
<P id=PARA54 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA55 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Special Shareholder Meeting and </B><B>Pursuit o</B><B>f Nasdaq Capital Market Listing</B></FONT></P>
<P id=PARA56 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">As you may be aware, BIO-key is seeking shareholder approval to effect a reverse split of our common stock at some point during 2016. A special meeting has been called for later this month to approve a reverse split with share exchange ratios ranging from 1-for-4 to 1-for-12 at any time through December 31, 2016 as determined by our Board of Directors. The Board would effect a reverse split only if it were clear that such an action would likely position BIO-key common stock to meet the listing standards of the Nasdaq Capital Market. Although progress needs to be made on this front before we would pursue a listing, the Board believes a Nasdaq listing would help make BIO-key&#8217;s common stock accessible to a broader base of investors while also providing enhanced visibility for our Company and our solutions on a global basis.</FONT></P>
<P id=PARA57 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA58 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>In Summary</B></FONT></P>
<P id=PARA59 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We are encouraged about the industry and regulatory dynamics that are accelerating demand for stronger security measures, including two-factor authentication. We have been anticipating this trend for several years and working diligently to position BIO-key to fully participate in these opportunities. We believe that the industry, regulatory and technology elements are coming into alignment and that we have never been in a better position to drive improved top-line and bottom-line performance from our growing portfolio of solutions in 2016 and the years to come.</FONT></P>
<P id=PARA60 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA61 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We thank you for your support and look forward to updating you on our progress.</FONT></P>
<P id=PARA62 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA63 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Sincerely,</FONT></P>
<P id=PARA64 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA65 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Michael De Pasquale </FONT></P>
<P id=PARA66 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Chairman &amp; CEO</FONT></P>
<P id=PARA87.1 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT></P>
<DIV id=PGBK87  style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=PGFTR87  style="WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<DIV id=PGNUM87  style="FONT-SIZE: 10pt; WIDTH: 100%; TEXT-ALIGN: center">&nbsp;</DIV>
<HR style="HEIGHT: 2px; WIDTH: 100%; PAGE-BREAK-AFTER: always; COLOR: #000000" noShade>

<DIV id=PGHDR87  style="WIDTH: 100%; TEXT-ALIGN: left">&nbsp;</DIV></DIV>
<P id=PARA87.2 style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px">&nbsp;</P>
<P id=PARA71 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>BIO-key Safe Harbor Statement</B></FONT></P>
<P id=PARA72 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Certain statements contained in this press release may be construed as &#8220;forward-looking statements&#8221; as defined in the Private Securities Litigation Reform Act of 1995 (the &#8220;Act&#8221;).&nbsp; The words &#8220;estimate,&#8221; &#8220;project,&#8221; &#8220;intends,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;believes&#8221; and similar expressions are intended to identify forward-looking statements.&nbsp; Such forward-looking statements are made based on management&#39;s beliefs, as well as assumptions made by, and information currently available to, management pursuant to the &#8220;safe-harbor&#8221; provisions of the Act.&nbsp; These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements.&nbsp; These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, the impact on our business of the recent financial crisis in the global capital markets and negative global economic trends, our ability to attract and retain key personnel.&nbsp; For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see &#8220;Risk Factors&#8221; in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2014 and its other filings with the Securities and Exchange Commission.&nbsp; Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made.&nbsp; The Company also undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events. </FONT></P>
<P id=PARA73 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA74 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</FONT></P>
<P id=PARA75 style="TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><B>Investor &amp; Media Contacts: </B></FONT></P>
<P id=PARA76 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">David Collins or Tanya Kamatu</FONT></P>
<P id=PARA77 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Catalyst Global</FONT></P>
<P id=PARA78 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">212-924-9800</FONT></P>
<P id=PARA79 style="TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><FONT style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">bkyi@catalyst-ir.com </FONT></P></BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo.jpg
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  L *\# 2(  A$! Q$!_\0
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M  53\,6WQ0^*WQ>\:?!WX>^)%^U>&_!_@"Z.EW,MDX_=SRW)!+(ZX9?-67S
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DJUO;C3;96@M3):V5M86^V-&"HL=K9VT2H@"A85XSDDT#4__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
